Michael M Friedman

This inventor holds 21 USPTO granted patents and 1 published patent application, plus 5 CIPO patents and 3 EPO patents, primarily in Kinase Inhibitors. Top assignees: Abbvie Inc., Abbott Gmbh & Co Kg, Abbott Laboratories Corporation. Active years: 2003-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael M Friedman. Retrieved from https://idiyas.com/inventor/michael-m-friedman-uzxdf2ri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 1)

% Patents Active = 90.5

CIPO Patents = 5 (Patent Applications = 6)

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 9.9

ph-index = 10

Forward Citations = 1,020(Granted Patents)

Location History:

Newton, MA (US) (2003 - 2015)
Brookline, MA (US) (2013 - 2019)
Kennebunkport, ME (US) (2019)

Company Filing History:

Abbott Laboratories Corporation

patents

Years Active: 2003-2019

Loading Chart...

Areas of Expertise:

Tyrosine Kinase

Heterocyclic Inhibitors

TNF Signaling

Tricyclic Compounds

Cyanoguanidines

BTK Inhibitors

Nuclear Hormone Receptors

Chemokine Receptor Antagonists

Pyrazolopyrimidines

Indazolones

Aminopyrrolidines

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10508113 - Inhibitors of tyrosine kinase 2 mediated signaling (2019-12-17),

2. 10280184 - Heterocyclic kinase inhibitors (2019-05-07),

3. 10273238 - Indazolones as modulators of TNF signaling (2019-04-30),

4. 10266532 - Tricyclic modulators of TNF signaling (2019-04-23),

5. RE47221 - Tricyclic compounds (2019-02-04),

6. 10160748 - Indazolones as modulators of tnf signaling (2018-12-25),

7. 10112911 - Substituted cyanoguanidines as oral anti-virals (2018-10-30),

8. 9879016 - Indazolones as modulators of TNF signaling (2018-01-30),

9. 9856253 - Tricyclic modulators of TNF signaling (2018-01-02),

10. 9567339 - Primary carboxamides as BTK inhibitors (2017-02-14),

11. 9365579 - Tricyclic compounds (2016-06-14),

12. 9193744 - Heterocyclic nuclear hormone receptor modulators (2015-11-24),

13. 9150592 - Heterocyclic nuclear hormone receptor modulators (2015-10-06),

14. 9115151 - Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and uses thereof (2015-08-25),

15. 8962629 - Tricyclic compounds (2015-02-24),

Title: The Inventor Michael M Friedman: Pioneering Innovations in Newton, MA

Introduction: Michael M Friedman is a distinguished inventor based in Newton, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Michael M Friedman holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Michael M Friedman has consistently demonstrated a knack for identifying gaps in the market and developing innovative solutions to address them. His inventions have not only improved existing processes but have also opened up new possibilities in the industry.

Collaborations: Throughout his career, Michael M Friedman has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Michael M Friedman's passion for innovation, coupled with his dedication to pushing the boundaries of what is possible, has solidified his reputation as a visionary inventor in Newton, MA, and beyond.

Profile summary based on public USPTO records.